These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 11332334
1. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension. Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group. Blood Press; 2001; 10(1):43-51. PubMed ID: 11332334 [Abstract] [Full Text] [Related]
2. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators. Zuschke CA, Keys I, Munger MA, Carr AA, Marinides GN, Flanagan TL, Cushing DJ, Hayes JL, Michelson EL. Clin Ther; 1999 Mar; 21(3):464-74. PubMed ID: 10321416 [Abstract] [Full Text] [Related]
3. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring. Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM. Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350 [Abstract] [Full Text] [Related]
4. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide. Ohma KP, Milon H, Valnes K. Blood Press; 2000 Apr; 9(4):214-20. PubMed ID: 11055474 [Abstract] [Full Text] [Related]
5. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF. J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052 [Abstract] [Full Text] [Related]
6. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. Asmar R, Lacourcière Y. J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784 [Abstract] [Full Text] [Related]
10. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil. Sever PS. J Hypertens Suppl; 1997 Dec; 15(6):S9-12. PubMed ID: 9493121 [Abstract] [Full Text] [Related]
11. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Lacourcière Y, Asmar R. Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580 [Abstract] [Full Text] [Related]
14. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR. Clin Drug Investig; 2007 Dec; 27(6):407-17. PubMed ID: 17506591 [Abstract] [Full Text] [Related]
15. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL, Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol; 2001 Mar 15; 87(6):727-31. PubMed ID: 11249891 [Abstract] [Full Text] [Related]
17. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Am J Cardiol; 1998 Oct 15; 82(8):961-5. PubMed ID: 9794352 [Abstract] [Full Text] [Related]
18. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care. Edes I, Multicentre Study Group. Clin Drug Investig; 2009 Oct 15; 29(5):293-304. PubMed ID: 19366271 [Abstract] [Full Text] [Related]
19. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. Cuspidi C, Muiesan ML, Valagussa L, Salvetti M, Di Biagio C, Agabiti-Rosei E, Magnani B, Zanchetti A, CATCH investigators. J Hypertens; 2002 Nov 15; 20(11):2293-300. PubMed ID: 12409969 [Abstract] [Full Text] [Related]